You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

ACOG MEMBER SUBSCRIPTION ACCESS

If you are an ACOG Fellow and have not logged in or registered to Obstetrics & Gynecology, please follow these step-by-step instructions to access journal content with your member subscription.

Nifedipine and Ritodrine in the Management of Preterm Labor: A Randomized Multicenter Trial.

PAPATSONIS, D. N. M. MD; VAN GEIJN, H. P. MD, PhD; ADÈR, H. J. PhD; LANGE, F. M. MD; BLEKER, O. P. MD, PhD; DEKKER, G. A. MD, PhD
Obstetrics & Gynecology:
Articles: PDF Only
Abstract

Objective: To compare the efficacy of nifedipine with ritodrine in the management of preterm labor.

Methods: One hundred eighty-five singleton pregnancies with preterm labor were assigned randomly to either ritodrine intravenously (n = 90) or nifedipine orally (n = 95). The principal outcome assessed was delay of delivery.

Results: Ritodrine was discontinued in 12 patients because of severe maternal side effects, and their results were excluded from further analysis. More women in the ritodrine group delivered within 24 hours (22 versus 11, P = .006), within 48 hours (29 versus 21, P = .03), within 1 week (45 versus 36, P = .009), and within 2 weeks (52 versus 43, P = .005) compared with those receiving nifedipine. There were significantly fewer maternal side effects in the nifedipine group. Apgar scores and umbilical artery and vein pHs were similar in both groups. The number of admissions to the neonatal intensive care unit (NICU) in the nifedipine group was significantly lower than in the ritodrine group (68.4 versus 82.1%, P = .04).

Conclusion: Nifedipine in comparison with ritodrine in the management of preterm labor is significantly associated with a longer postponement of delivery, fewer maternal side effects, and fewer admissions to the NICU.

(C) 1997 The American College of Obstetricians and Gynecologists

In Brief

Compared with ritodrine, nifedipine is associated with a longer postponement of delivery, fewer maternal side effects, and fewer admissions to the neonatal intensive care unit.